Pedro Casado

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Nature communications

Signal transduction and targeted therapy

Leukemia

Science signaling

Barts Cancer Institute

Universidad de Oviedo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Barts Cancer Institute Oct 01 2013

United Kingdom

Post Doctoral Research Assistant :: Centre for Haemato-Oncology

Barts Cancer Institute Jun 04 2009 - Sep 30 2013

United Kingdom

Post Doctoral Research Assistant :: Centre for Cell Signalling

Education History

Universidad de Oviedo Nov 01 2002 - Jun 16 2008

Spain

PHD :: Biochemistry and Molecular Biology

Publications

Vilma Dembitz, Hannah Lawson, Richard Burt, Sirisha Natani, Céline Philippe, Sophie C James, Samantha Atkinson, Jozef Durko, Lydia M Wang, Joana Campos, Aoife M S Magee, Keith Woodley, Michael James Austin, Ana Rio-Machin, Pedro Casado, Findlay Bewicke-Copley, Giovanny Rodriguez Blanco, Diego Pereira-Martins, Lieve Oudejans, Emeline Boet, Alex von Kriegsheim, Juerg Schwaller, Andrew J Finch, Bela Patel, Jean-Emmanuel Sarry, Jerome Tamburini, Jan Jacob Schuringa, Lori Hazlehurst, John A Copland Iii, Mariia Yuneva, Barrie Peck, Pedro Rodriguez Cutillas, Jude Fitzgibbon, Kevin Rouault-Pierre, Kamil R Kranc, Paolo Gallipoli
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia (2024)
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, Findlay Bewicke-Copley, Kevin Rouault-Pierre, Szilvia Krizsán, Alun Parsons, Vinothini Rajeeve, Farideh Miraki-Moud, David C Taussig, Csaba Bödör, John Gribben, Caroline A Heckman, Jude Fitzgibbon, Pedro Rodriguez Cutillas
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal transduction and targeted therapy 8 (1) (2023)
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, Findlay Bewicke-Copley, Kevin Rouault-Pierre, Szilvia Krizsán, Alun Parsons, Vinothini Rajeeve, Farideh Miraki-Moud, David C Taussig, Csaba Bödör, John Gribben, Caroline A Heckman, Jude Fitzgibbon, Pedro Rodriguez Cutillas
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal transduction and targeted therapy 8 (1) (2023)
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, Findlay Bewicke-Copley, Kevin Rouault-Pierre, Szilvia Krizsán, Alun Parsons, Vinothini Rajeeve, Farideh Miraki-Moud, David C Taussig, Csaba Bödör, John Gribben, Caroline A Heckman, Jude Fitzgibbon, Pedro Rodriguez Cutillas
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal transduction and targeted therapy 8 (1) (2023)
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, Findlay Bewicke-Copley, Kevin Rouault-Pierre, Szilvia Krizsán, Alun Parsons, Vinothini Rajeeve, Farideh Miraki-Moud, David C Taussig, Csaba Bödör, John Gribben, Caroline A Heckman, Jude Fitzgibbon, Pedro Rodriguez Cutillas
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal transduction and targeted therapy 8 (1) (2023)
William Grey, Ana Rio-Machin, Pedro Casado, Eva Grönroos, Sara Ali, Juho J Miettinen, Findlay Bewicke-Copley, Alun Parsons, Caroline A Heckman, Charles Swanton, Pedro Rodriguez Cutillas, John G Gribben, Jude Fitzgibbon, Dominique Bonnet
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia. Science translational medicine 14 (650) (2022)
Federico Pedicona, Pedro Casado, Maruan Hijazi, John G Gribben, Kevin Rouault-Pierre, Pedro Rodriguez Cutillas
Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment. Science signaling 15 (730) (2022)
Henry Gerdes, Pedro Casado, Arran Dokal, Maruan Hijazi, Nosheen Akhtar, Ruth Osuntola, Vinothini Rajeeve, Jude Fitzgibbon, Jon Travers, David Britton, Shirin Elizabeth Khorsandi, Pedro Rodriguez Cutillas
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs. Nature communications 12 (1) (2021)
Kathryn Davidson, Paul Grevitt, María F Contreras-Gerenas, Katherine S Bridge, Miguel Hermida, Kunal M Shah, Faraz K Mardakheh, Mark Stubbs, Rosemary Burke, Pedro Casado, Pedro Rodriguez Cutillas, Sarah A Martin, Tyson V Sharp
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes. Cell death & disease 12 (11) (2021)
Angelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, Maria Lillina Vignola, James G Nicholson, Rachael Tan, Shin-Ichi Inoue, Valeria Scagliotti, Pedro Casado, James Blackburn, Fernando Abollo-Jimenez, Eugenia Marinelli, Rachel Elizabeth Jane Besser, Wolfgang Högler, I Karen Temple, Justin H Davies, Andrey Gagunashvili, Iain C A F Robinson, Sally Ann Camper, Shannon W Davis, Pedro Rodriguez Cutillas, Evelien F Gevers, Yoko Aoki, Mehul Tulsidas Dattani, Carles Gaston-Massuet
Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans. Nature communications 12 (1) (2021)
Guillermo Fernández-Varo, Meritxell Perramón, Silvia Carvajal, Denise Oró, Eudald Casals, Loreto Boix, Laura Oller, Laura Macías-Muñoz, Santi Marfà, Gregori Casals, Manuel Morales-Ruiz, Pedro Casado, Pedro R Cutillas, Jordi Bruix, Miquel Navasa, Josep Fuster, Juan Carlos Garcia-Valdecasas, Mihai C Pavel, Víctor Puntes, Wladimiro Jiménez
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 72 (4) (2021)
Fevzi Demircioglu, Jun Wang, Juliana Candido, Ana S H Costa, Pedro Casado, Beatriz de Luxan Delgado, Louise E Reynolds, Jesus Gomez-Escudero, Emma Newport, Vinothini Rajeeve, Ann-Marie C Baker, Marina Roy-Luzarraga, Trevor A Graham, Julie Foster, Yu Wang, James J Campbell, Rajinder Singh, Penglie Zhang, Thomas J Schall, Frances R Balkwill, Jane Sosabowski, Pedro Rodriguez Cutillas, Christian Frezza, Patricia Sancho, Kairbaan Hodivala-Dilke
Cancer associated fibroblast FAK regulates malignant cell metabolism. Nature communications 11 (1) (2020)
Pedro Casado, Edmund H Wilkes, Farideh Miraki-Moud, Marym Mohammad Hadi, Ana Rio-Machin, Vinothini Rajeeve, Rebecca Pike, Sameena Iqbal, Santiago Marfa, Nicholas Lea, Steven Best, John Gribben, Jude Fitzgibbon, Pedro Rodriguez Cutillas
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells. Leukemia 32 (8) (2018)
Ana Angulo-Urarte, Pedro Casado, Sandra D Castillo, Piotr Kobialka, Maria Paraskevi Kotini, Ana M Figueiredo, Pau Castel, Vinothini Rajeeve, Maria Milà-Guasch, Jaime Millan, Cora Wiesner, Helena Serra, Laia Muixi, Oriol Casanovas, Francesc Viñals, Markus Affolter, Holger Gerhardt, Stephan Huveneers, Heinz-Georg Belting, Pedro R Cutillas, Mariona Graupera
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility. Nature communications 9 (1) (2018)
Saúl Álvarez-Teijeiro, Cristina García-Inclán, M Ángeles Villaronga, Pedro Casado, Francisco Hermida-Prado, Rocío Granda-Díaz, Juan Pablo Rodrigo, Fernando Calvo, Nagore Del-Río-Ibisate, Alberto Gandarillas, Francisco Morís, Mario Hermsen, Pedro Cutillas, Juana María García-Pedrero
Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets. Cancers 10 (9) (2018)

Pedro Casado.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pedro Casado